Pharmaceuticals Market
Pharmaceuticals Market Forecasts to 2030 - Global Analysis By Product Type (Branded Drugs, Generic Drugs, OTC (Over-the-Counter) Drugs, Biopharmaceuticals, Vaccines and Other Product Types), Route of administration, Therapy Area, End User and By Geography
According to Stratistics MRC, the Global Pharmaceuticals Market is accounted for $1.6 billion in 2024 and is expected to reach $2.6 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Pharmaceuticals are drugs and medications developed for use in medical diagnosis, treatment, prevention, and alleviation of diseases. This field encompasses the entire process from the discovery of new compounds to their development, testing, regulatory approval, production, and distribution. Pharmaceuticals include a wide range of products, from over-the-counter drugs to prescription medications, vaccines, and biologics. The industry is highly regulated to ensure drug safety, efficacy, and quality, requiring extensive research, clinical trials, and adherence to standards set by authorities like the FDA. Pharmaceuticals play a critical role in modern healthcare, enabling the management of various health conditions, enhancing patient outcomes, and contributing to public health.
Market Dynamics:
Driver:
Increasing incidence of chronic diseases increases
Increasing incidence of chronic diseases drives demand for ongoing medication, specialized treatments, and innovative therapies, leading to higher sales and revenue growth for pharmaceutical companies. This trend also stimulates research and development investments, fostering the creation of new and improved drugs. Additionally, it encourages partnerships and collaborations within the industry to address complex health challenges propelling the markets growth.
Restraint:
Public scrutiny of high drug prices
Public scrutiny can lead to increased regulatory pressure and legislative actions aimed at controlling or reducing drug prices. It may also result in reputational damage, affecting stock prices and investor confidence. Companies might face reduced profit margins, hampering their ability to invest in research and development for new drugs hampering its growth during the forecast period.
Opportunity:
Increased government spending on healthcare
Increased government nvestment enhances healthcare infrastructure and supports broader distribution of essential drugs, driving higher demand and sales for pharmaceutical companies. It also funds research and development initiatives, fostering innovation and the introduction of new therapies. Moreover, government spending often includes subsidies and reimbursement programs, making medications more affordable for patients encouraging growth of the market.
Threat:
Generic competition
Patents for branded drugs expire, generic drug makers can produce and sell cheaper versions of these medications, leading to a sharp decline in the sales of the original products. This increased availability of lower-cost alternatives drives down prices across the market, reducing profit margins for both brand-name and generic pharmaceutical companies thereby the presence of generics also forces branded drug manufacturers to invest more in marketing and innovation to differentiate their products, increasing operational costs.
Covid-19 Impact:
The COVID-19 pandemic profoundly impacted the pharmaceuticals market, accelerating innovation and the development of vaccines and treatments. It increased demand for medications, diagnostics, and healthcare supplies, boosting revenues for many companies. However, it also disrupted supply chains, delayed clinical trials, and strained resources. The crisis emphasized the importance of agility and collaboration in the industry, leading to rapid advancements and a renewed focus on global health preparedness and resilience against future pandemics.
The branded drugs segment is expected to be the largest during the forecast period
The branded drugs is expected to be the largest during the forecast period because these drugs, protected by patents, allow pharmaceutical companies to recoup research and development costs and fund further innovation. They often command higher prices, contributing to substantial revenue and profitability for their manufacturers and branded drugs remain crucial for advancing medical treatments and addressing unmet healthcare needs.
The oncology segment is expected to have the highest CAGR during the forecast period
The oncology segment is expected to have the highest CAGR during the forecast period owing to the high prevalence of cancer worldwide creates substantial demand for effective treatments, positioning oncology as a top priority for pharmaceutical companies. This focus leads to the development of innovative therapies, including targeted treatments, immunotherapy’s, and personalized medicine, which command high prices and generate substantial revenue ensuring sustained growth and innovation within the industry.
Region with largest share:
North America is projected to hold the largest market share during the forecast period North America, particularly the U.S., represents a significant portion of the global pharmaceuticals market. The market is characterized by strong growth due to aging populations, increasing prevalence of chronic diseases, and high demand for innovative treatments. Further the region is a leader in pharmaceutical innovation, with substantial investments in research and development.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period as the Asia-Pacific region is experiencing significant growth due to increasing healthcare needs, rising disposable incomes, and expanding access to healthcare services. Countries like China and India are major contributors to this growth, with their large populations and improving healthcare infrastructure. Local companies are major players in the generic drug market, contributing to the region’s growing pharmaceutical industry.
Key players in the market
Some of the key players in Pharmaceuticals market include Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis International AG, Merck & Co., Inc. (MSD), Bristol-Myers Squibb, Sanofi, GlaxoSmithKline, AstraZeneca, AbbVie Inc., Eli Lilly and Company, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, Gilead Sciences, Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc. and Biogen Inc.
Key Developments:
In July 2024, Johnson & Johnson strengthened pipeline to lead in atopic dermatitis with acquisition of Yellow Jersey Therapeutics. The company is leveraging a multi-pathway approach to transform treatment in atopic dermatitis and other immune-mediated diseases
In June 2024, Pfizer Inc. and BioNTech received positive CHMP opinion for Omicron JN.1-adapted COVID-19 vaccine in the European Union. The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
In June 2024, Bayer receives breakthrough therapy designation in China for BAY 2927088 in high unmet need patients with HER2-mutant non-small cell lung cancer. The Center for Drug Evaluation in China has granted breakthrough therapy designation to expedite the development
Product Types Covered:
• Branded Drugs
• Generic Drugs
• OTC (Over-the-Counter) Drugs
• Biopharmaceuticals
• Vaccines
• Other Product Types
Route of administrations Covered:
• Oral
• Injectable
• Topical
• Inhalation
• Transdermal
• Nasal
• Other Route of administrations
Therapy Areas Covered:
• Oncology
• Cardiovascular Diseases
• Neurology
• Respiratory Diseases
• Gastrointestinal Disorders
• Infectious Diseases
• Diabetes
• Other Therapy Areas
End Users Covered:
• Clinics
• Hospitals
• Home Care Settings
• Research & Academic Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceuticals Market, By Product Type
5.1 Introduction
5.2 Branded Drugs
5.3 Generic Drugs
5.4 OTC (Over-the-Counter) Drugs
5.5 Biopharmaceuticals
5.6 Vaccines
5.7 Other Product Types
6 Global Pharmaceuticals Market, By Route of administration
6.1 Introduction
6.2 Oral
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Liquids
6.2.4 Syrups
6.3 Injectable
6.3.1 Intravenous
6.3.2 Intramuscular
6.3.3 Subcutaneous
6.3.4 Infusions
6.4 Topical
6.4.1 Creams
6.4.2 Ointments
6.4.3 Gels
6.4.4 Patches
6.5 Inhalation
6.5.1 Metered-Dose Inhalers
6.5.2 Dry Powder Inhalers
6.5.3 Nebulizers
6.6 Transdermal
6.7 Nasal
6.8 Other Route of administrations
7 Global Pharmaceuticals Market, By Therapy Area
7.1 Introduction
7.2 Oncology
7.3 Cardiovascular Diseases
7.4 Neurology
7.5 Respiratory Diseases
7.6 Gastrointestinal Disorders
7.7 Infectious Diseases
7.8 Diabetes
7.9 Other Therapy Areas
8 Global Pharmaceuticals Market, By End User
8.1 Introduction
8.2 Clinics
8.3 Hospitals
8.4 Home Care Settings
8.5 Research & Academic Institutes
8.6 Other End Users
9 Global Pharmaceuticals Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Pfizer Inc.
11.2 Johnson & Johnson
11.3 Roche Holding AG
11.4 Novartis International AG
11.5 Merck & Co., Inc. (MSD)
11.6 Bristol-Myers Squibb
11.7 Sanofi
11.8 GlaxoSmithKline
11.9 AstraZeneca
11.10 AbbVie Inc.
11.11 Eli Lilly and Company
11.12 Bayer AG
11.13 Amgen Inc.
11.14 Takeda Pharmaceutical Company Limited
11.15 Boehringer Ingelheim
11.16 Gilead Sciences, Inc.
11.17 Novo Nordisk A/S
11.18 Teva Pharmaceutical Industries Ltd.
11.19 Astellas Pharma Inc.
11.20 Biogen Inc.
List of Tables
1 Global Pharmaceuticals Market Outlook, By Region (2022-2030) ($MN)
2 Global Pharmaceuticals Market Outlook, By Product Type (2022-2030) ($MN)
3 Global Pharmaceuticals Market Outlook, By Branded Drugs (2022-2030) ($MN)
4 Global Pharmaceuticals Market Outlook, By Generic Drugs (2022-2030) ($MN)
5 Global Pharmaceuticals Market Outlook, By OTC (Over-the-Counter) Drugs (2022-2030) ($MN)
6 Global Pharmaceuticals Market Outlook, By Biopharmaceuticals (2022-2030) ($MN)
7 Global Pharmaceuticals Market Outlook, By Vaccines (2022-2030) ($MN)
8 Global Pharmaceuticals Market Outlook, By Other Product Types (2022-2030) ($MN)
9 Global Pharmaceuticals Market Outlook, By Route of administration (2022-2030) ($MN)
10 Global Pharmaceuticals Market Outlook, By Oral (2022-2030) ($MN)
11 Global Pharmaceuticals Market Outlook, By Tablets (2022-2030) ($MN)
12 Global Pharmaceuticals Market Outlook, By Capsules (2022-2030) ($MN)
13 Global Pharmaceuticals Market Outlook, By Liquids (2022-2030) ($MN)
14 Global Pharmaceuticals Market Outlook, By Syrups (2022-2030) ($MN)
15 Global Pharmaceuticals Market Outlook, By Injectable (2022-2030) ($MN)
16 Global Pharmaceuticals Market Outlook, By Intravenous (2022-2030) ($MN)
17 Global Pharmaceuticals Market Outlook, By Intramuscular (2022-2030) ($MN)
18 Global Pharmaceuticals Market Outlook, By Subcutaneous (2022-2030) ($MN)
19 Global Pharmaceuticals Market Outlook, By Infusions (2022-2030) ($MN)
20 Global Pharmaceuticals Market Outlook, By Topical (2022-2030) ($MN)
21 Global Pharmaceuticals Market Outlook, By Creams (2022-2030) ($MN)
22 Global Pharmaceuticals Market Outlook, By Ointments (2022-2030) ($MN)
23 Global Pharmaceuticals Market Outlook, By Gels (2022-2030) ($MN)
24 Global Pharmaceuticals Market Outlook, By Patches (2022-2030) ($MN)
25 Global Pharmaceuticals Market Outlook, By Inhalation (2022-2030) ($MN)
26 Global Pharmaceuticals Market Outlook, By Metered-Dose Inhalers (2022-2030) ($MN)
27 Global Pharmaceuticals Market Outlook, By Dry Powder Inhalers (2022-2030) ($MN)
28 Global Pharmaceuticals Market Outlook, By Nebulizers (2022-2030) ($MN)
29 Global Pharmaceuticals Market Outlook, By Transdermal (2022-2030) ($MN)
30 Global Pharmaceuticals Market Outlook, By Nasal (2022-2030) ($MN)
31 Global Pharmaceuticals Market Outlook, By Other Route of administrations (2022-2030) ($MN)
32 Global Pharmaceuticals Market Outlook, By Therapy Area (2022-2030) ($MN)
33 Global Pharmaceuticals Market Outlook, By Oncology (2022-2030) ($MN)
34 Global Pharmaceuticals Market Outlook, By Cardiovascular Diseases (2022-2030) ($MN)
35 Global Pharmaceuticals Market Outlook, By Neurology (2022-2030) ($MN)
36 Global Pharmaceuticals Market Outlook, By Respiratory Diseases (2022-2030) ($MN)
37 Global Pharmaceuticals Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
38 Global Pharmaceuticals Market Outlook, By Infectious Diseases (2022-2030) ($MN)
39 Global Pharmaceuticals Market Outlook, By Diabetes (2022-2030) ($MN)
40 Global Pharmaceuticals Market Outlook, By Other Therapy Areas (2022-2030) ($MN)
41 Global Pharmaceuticals Market Outlook, By End User (2022-2030) ($MN)
42 Global Pharmaceuticals Market Outlook, By Clinics (2022-2030) ($MN)
43 Global Pharmaceuticals Market Outlook, By Hospitals (2022-2030) ($MN)
44 Global Pharmaceuticals Market Outlook, By Home Care Settings (2022-2030) ($MN)
45 Global Pharmaceuticals Market Outlook, By Research & Academic Institutes (2022-2030) ($MN)
46 Global Pharmaceuticals Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
